Vanta Bioscience Limited

Healthcare · Healthcare Services

BSE: 540729
₹22.62
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Apollo Hospitals Enterprise Limited 117,407 74.7 20.1% 9.7% — 73 0 27
Max Healthcare Institute Limited 90,492 126.0 13.4% -16.5% 0.22% 77 0 26
Fortis Healthcare Limited 58,132 257.5 10.5% -22.2% 0.13% 49 26 6
Global Health Limited 36,701 76.2 13.9% 4.6% 0.04% 74 0 30
Narayana Hrudayalaya Ltd. 36,609 64.4 17.8% 3.5% 0.25% 66 0 29
Aster DM Quality Care Limited 36,121 207.5 8.8% 10.5% 0.43% 53 0 26
Dr. Lal Path Labs Ltd. 33,310 38.7 20.1% -37.3% 0.98% 82 0 88
Krishna Institute of Medical Sciences Limited 31,349 111.2 9.5% 8.5% — 47 0 29

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet. EBITDA = PBT + interest + depreciation.

Enterprise value
Data unavailable.
EV / EBITDA
Data unavailable.
EV / Sales
Data unavailable.
Market cap / Sales
Data unavailable.
Earnings yield
Data unavailable.

Quarterly Financials

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
Sept. 30, 2022 2 -1 -2 ₹

Quarterly income statement (standalone, ₹ Cr)

IndicatorSep 22
Total income (before exceptional items)2
Operating revenue2
Other income0
Operating expenses1
Operating profit0
Operating profit margin18.9%
Depreciation1
Interest1
Exceptional items, gain / (loss)—
Profit before tax-1
Tax0
Net profit-2
EPS—
Net profit (TTM)—
EPS (TTM)—

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Data unavailable (annual figures are only available from the NSE iXBRL feed's coverage period).

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 -5 -7 12 0 -5
March 31, 2025 1 -5 4 -1 1

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 66 — — — — 15 12 0 10 8
March 31, 2025 56 — — — — 10 19 0 11 6